Brandywine Global Investment Management’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-89,700
| Closed | -$169K | – | 569 |
|
|
2024
Q3 | $169K | Sell |
89,700
-38,500
| -30% | -$72.4K | ﹤0.01% | 651 |
|
|
2024
Q2 | $949K | Sell |
128,200
-17,400
| -12% | -$129K | 0.01% | 632 |
|
|
2024
Q1 | $1.14M | Hold |
145,600
| – | – | 0.01% | 626 |
|
|
2023
Q4 | $740K | Sell |
145,600
-28,900
| -17% | -$147K | 0.01% | 654 |
|
|
2023
Q3 | $1.03M | Buy |
+174,500
| New | +$1.03M | 0.01% | 629 |
|